If you suffered losses exceeding $50,000 in Atkore between February 1, 2024 and February 3, 2025 and would like to discuss ...

If you purchased or acquired securities in BioAge between September 26, 2024 and January 7, 2025 and would like to discuss ...

If you suffered losses exceeding $50,000 in ESSA Pharma between December 12, 2023 and October 31, 2024 and would like to ...

If you suffered losses exceeding $100,000 in Elastic between May 31, 2024 and August 29, 2024 and would like to discuss your ...

If you purchased or acquired securities in Trade Desk between May 9, 2024 and February 12, 2025 and would like to discuss ...

If you suffered losses exceeding $75,000 in Semtech between August 27, 2024 and February 7, 2025 and would like to discuss ...

If you suffered losses exceeding $50,000 in ModivCare between November 3, 2022 and May 3, 2023 and would like to discuss your ...

New York, New York-- (Newsfile Corp. - March 11, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Viatris Inc. ("Viatris" or the "Company ...

If you suffered losses exceeding $75,000 in ICON between July 27, 2023 and October 23, 2024 and would like to discuss your ...

Wilson Encourages Investors Who Suffered Significant Losses In Pliant Therapeutics To Contact Him Directly To Discuss Their ...

If you suffered losses exceeding $100,000 in AppLovin between May 10, 2023 to February 25, 2025 and would like to discuss ...

New York, New York-- (Newsfile Corp. - March 7, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is ...